Format

Send to

Choose Destination
Eur J Neurol. 2018 Jul;25(7):943-e71. doi: 10.1111/ene.13625. Epub 2018 Apr 15.

A novel heterozygous variant in ERLIN2 causes autosomal dominant pure hereditary spastic paraplegia.

Author information

1
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
2
Department of Neurology, Oslo University Hospital, Oslo, Norway.
3
Department of Neurology, University of Rostock, Rostock, Germany.
4
German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany, Germany.
5
CeGaT GmbH, Center for Genomics and Transcriptomics, Tübingen, Germany.
6
Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany.
7
Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.

Abstract

BACKGROUND AND PURPOSE:

Hereditary spastic paraplegias (HSPs) are clinically and genetically heterogeneous monogenic disorders. To date, nearly 70 genes are known to be causative. The aim of this project was to identify the genetic cause of autosomal dominantly inherited pure HSP in two large, unrelated non-consanguineous families.

METHODS:

The two families were characterized clinically and selected members underwent whole exome sequencing. Potentially disease-causing variants were confirmed by Sanger sequencing and their functional consequences on protein function were predicted by bioinformatic prediction tools.

RESULTS:

The patients presented with pure spastic paraplegia with age of onset between 9 and 46 years. In both families, a novel heterozygous missense variant in ERLIN2, c.386G>C; p.Ser129Thr, was the only potentially pathogenic variant identified that segregated with the disease.

CONCLUSIONS:

Biallelic variants in ERLIN2 are known to cause recessive HSP type SPG18. Here, the first two families with an autosomal dominant, pure form of HSP caused by a novel ERLIN2 heterozygous missense variant are described. These findings expand the mutational and inheritance spectrum of SPG18. ERLIN2 variants should also be considered in the diagnostic evaluation of patients with autosomal dominant HSP.

KEYWORDS:

ERLIN2 ; ERAD; SPG18; autosomal dominant; hereditary spastic paraplegia; neurodegeneration; next generation sequencing

PMID:
29528531
DOI:
10.1111/ene.13625
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center